Natick, MA, United States of America

Mukund Shankar Chorghade

This inventor holds 22 USPTO granted patents and 1 published patent application, primarily in Organic Synthesis. Top assignees: Genzyme Corporation, Millennium Pharmaceuticals Limited, Millenium Pharmaceuticals, Inc.. Active years: 2001-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mukund Shankar Chorghade. Retrieved from https://idiyas.com/inventor/mukund-shankar-chorghade

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 

% Patents Active = 86.4

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Wellesley, MA (US) (2001)
  • Natick, MA (US) (2001 - 2009)

Company Filing History:


Years Active: 2001-2009

Loading Chart...
Areas of Expertise:
Chiral Amino Acids
Thiazoline Compounds
Alicyclic Chemistry
Phase Transfer Catalysis
Substituted Benzonitriles
Heterocyclic Compounds
Tetrahydrofuran
Amino Acid Synthesis
Carboxylic Acids
Substituted Thiazolines
Benzimidate Synthesis
Organic Chemistry
22 patents (USPTO):Explore Patents

Title: Mukund Shankar Chorghade: A Pioneer in Synthesis and Drug Development

Introduction

Mukund Shankar Chorghade, located in Natick, MA, is a prominent inventor with an extensive portfolio comprising 22 patents. His work has significantly contributed to the field of pharmaceutical chemistry, particularly through the innovative synthesis of amino acids and chelating agents.

Latest Patents

Chorghade's recent patents highlight his expertise in synthesizing 2-alkyl amino acids, which are essential for creating a diverse range of pharmaceutically active agents. His method involves a Michael-type addition of a nucleophile to dialkyl 2-methylidenylpropan-1,3-dioate, followed by converting an ester moiety into an amino moiety. Additionally, he has developed a method for preparing iron chelating agents related to desferrithiocin that incorporate a thiazoline ring through the condensation of an aryl nitrile or imidate with cysteine derivatives.

Another notable patent includes a process for synthesizing 4-methylthiazole-4(S)-carboxylic acid compounds. This invention presents a straightforward synthesis for ethyl 2,4-dihydroxybenzimidate and its ethers from 2,4-dihydroxybenzoic acid. Here, he also applies the method for preparing a class of iron chelating agents, reinforcing his focus on medicinal compounds.

Career Highlights

Throughout his career, Chorghade has been associated with prominent companies such as Genzyme Corporation and Millennium Pharmaceuticals Limited. His experience in these organizations has immensely enriched his understanding and expertise in pharmaceutical research and development.

Collaborations

Mukund Shankar Chorghade has collaborated with notable coworkers, including Mukund K Gurjar and Sunil Vyankatesh Mhaskar. These partnerships have further advanced the innovations in his field, showcasing the importance of teamwork in the pursuit of scientific breakthroughs.

Conclusion

Mukund Shankar Chorghade stands out as an influential inventor in the synthesis of pharmaceutical compounds. His contributions continue to shape the landscape of drug development, demonstrating the vital role of innovation in improving healthcare solutions. With a robust collection of patents and a history of fruitful collaborations, his work is poised to make lasting impacts in the realm of medicinal chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…